Effects of Breast Cancer and Mastectomy on Fibrinolytic Activity in African Women

Elusoji S.O Famodu


Reduced blood fibrinolytic activity (FA) has been postulated in cancer. It is good to know if this is also the case in Africans with breast cancer. Africans are known to possess enhanced fibrinolysis. This study was designed to assess the effect of breast cancer on fibrinolytic activity and the effect of mastectomy on fibrinolysis in African women.

Sixty histo-patholically proven breast cancer patients aged 25 - 45 years were compared with 50 healthy age-matched controls. Plasma fibrinogen levels and euglobulin lysis time (ELT) were estimated in breast cancer patients and the controls.

Patients with breast cancer had significantly increased fibrinogen levels euglobulin lysis time (P<0.001) compared with controls. There was significant mean difference between pre and post-mastectomy fibrinogen and euglobulin lysis time values (p<0.05). Progressive significant decrease in fibrinogen levels and euglobulin lysis time values (P<0.05) were observed over the weeks studied respectively. African women with breast cancer have defective fibrin clearing which could predispose them to thrombotic diathesis and early mastectomy may be beneficial. We suggest that fibrinolytic components may be a prognostic marker for breast cancer. (Afr J Reprod Health 2006; 10[3]:114-119)


Keywords: Fibrinolytic activity, Fibrinogen, Breast cancer, mastectomy

Full Text:



Troseeau A. Cinique Medicale de I' Hostel - Dieu de Paris: J.B Bailliere et fills 1869, 3:95 1869 - 1872.

Wynder EL., Rose DP, Cohen LA: Diet and breast cancer in Caucasian and therapy, Cancer 1986 58:813 - 820

O'meara RA. Coagulation properties of cancer. Journal of Medical Sciences. 1958; 394: 474 - 479

Boggust W.A., O' Brien, DJ; O'meara RAQ. Thomes RD. The coagulative factor of normal human cancer tissue. Journal Medical Science. 1963; 447:131 - 136

Peterson H1. Experimental studies on fibrinolysis in growth and spread of tumor. Acta Chir. Scand suppl. 1968; 394; - 398

Zackarski LR., Memoli VA., Constantini V., Wojtukiewilz MZ; Qesntein DL: Clotting factors in tumor tissue: Implications for cancer therapy. Blood coagulation and fibrinolysis. 1990; 171 - 176

Elusoji SO, "Aligbe JU, Idaewor PF; Aigbe A., Obarhua A, Famodu AA. Platelet counts in Nigerian Breast cancer patient. Nigeria Journal of Medicine 1997; 6 : 50 - 52

Gleeson NC, Gonsalves R. Bonnar J. Plasminogen activator inhibitors in endomentrial adenocarci-noma Cancer: 1993b 72: 1670 - 1672

Bouchet C Spyrators F, Martin P.M et al. Prognostic value of Urokinase type plasminogen activator (UPA) and plasminogen activator inhibitors Pal -1 and PAI-2 in breast carcinomas. British Journal of Cancer 1994, 69: 398 - 405

Foeken J.A., Schmitt M, van Putter W.L .J et al. Plasminogen activator inhibitor -1 and prognosis in primary breast cancer Journal of Clinical Ontology. 1994, 12: 1648 - 1658.

Essien EM. Enhanced fibrinolysis in Nigerians: Probable contributory factor to low prevalence of atherosclerosis in Nigerians. African Journal of Medical Science. 1976; 5: 287 - 290.

Lawani J., Ngu CA., Osunkoya BO. Clinicopatho-logical review of malignant disease of the breast in U.C.H Ibadan. Nigeria Journal of Medical Sciences 1973; 3: 82 - 85.

Megafu V: Cancer of the genital tract among Ibo women in Nigeria. Cancer 1979; 44: 1875 - 79.

Chiedozie LL. Breast Cancer in Nigeria women. 1985; 55: 653 - 658.

Badoe E.A and Ajayi O.O. The breast. In Badoe E.A, Achampong E.Q and Jaja MOA (Eds) Principles and Practice of Survey including Pathology in the Tropics. 2nd Ed. Accra: Ghana Publishing Corporation 1994, P. 430

Ihekwaba F.N. Breast cancer in Nigerian Women. British Journal of Surgery 1992; 29; 711 716.

Ingram GIC. A suggested schedule for the rapid investigation of acute haemostatic failure. Journal of Clinical Pathology 1961. 4: 356 - 360.

Haugie C.: Euglobulin lysis time (method). In: Haematology. William JW. Benller E. Ersley AJ. And Lichman 3rd Ed. McGraw Hill Books (Singapore) 1986. P.1670 - 1678.

Marsh NA. Measurement of Fibrinolytic capacity by the euglobulin lysis time method - a problem of units. Thrombosis Research. 1977; 12: 197 - 200

Lowe GDO. Plasma and blood viscosity. In Clinical Blood Rheology. Vol. 1 GDO. Lowe, ed; Boca Raton. 1998 P.11

Famodu AA Ajayi OI Obasohan AO. Platelet count and platelet factor 3 (PT-3) availability in hypertensive Nigerian. High Blood pressure and cardiovascular Prevention. 1998; 7:137 - 139.


  • There are currently no refbacks.